Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle C Cuneo

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Practical Radiation Oncology|June 4, 2014
Patterns of practice in radiation therapy for non-small cell lung cancer among members of the American Society for Radiation OncologyFeng-Ming Spring Kong, Kyle C Cuneo, Li Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|October 26, 2017
Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular CarcinomaEli Sapir, Yebin Tao, Matthew J Schipper, et al.
Physics in Medicine and Biology|February 13, 2023
Stereotactic body radiation therapy (SBRT) following Yttrium-90 (<sup>90</sup>Y) selective internal radiation therapy (SIRT): a feasibility planning study using<sup>90</sup>Y delivered doseStephen F Mee, Daniel F Polan, Yuni K Dewaraja, et al.
International Journal of Radiation Oncology, Biology, Physics|September 15, 2018
Magnetic Resonance Imaging Evaluation of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy: Long Term Imaging Follow-UpMishal Mendiratta-Lala, William Masch, Prasad R Shankar, et al.
Scientific Reports|January 26, 2019
PD-L1 Expression in Circulating Tumor Cells Increases during Radio(chemo)therapy and Indicates Poor Prognosis in Non-small Cell Lung CancerYang Wang, Tae Hyun Kim, Shamileh Fouladdel, et al.
Journal of Surgical Oncology|March 3, 2022
Factors associated with disease-free and abdominal recurrence-free survival in abdominopelvic and retroperitoneal sarcomasBrooke C Bredbeck, Lia D Delaney, Varun G Kathawate, et al.
Cancers|April 25, 2020
Expansion of Circulating Tumor Cells from Patients with Locally Advanced Pancreatic Cancer Enable Patient Derived Xenografts and Functional Studies for Personalized MedicineLianette Rivera-Báez, Ines Lohse, Eric Lin, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2023
Does Vascular Collapse Occur After Treatment of Hepatocellular Cancer With Stereotactic Body Radiation Therapy?Theodore S Lawrence, Madhava P Aryal, Joseph R Evans, et al.
Translational Oncology|May 12, 2019
Serum Levels of Hepatocyte Growth Factor and CD40 Ligand Predict Radiation-Induced Liver InjuryKyle C Cuneo, Theresa Devasia, Yilun Sun, et al.
International Journal of Radiation Oncology, Biology, Physics|September 9, 2019
Phase 2 Trial of Neoadjuvant FOLFIRINOX and Intensity Modulated Radiation Therapy Concurrent With Fixed-Dose Rate-Gemcitabine in Patients With Borderline Resectable Pancreatic CancerNguyen H Tran, Vaibhav Sahai, Kent A Griffith, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Practical Radiation Oncology|June 4, 2014
Patterns of practice in radiation therapy for non-small cell lung cancer among members of the American Society for Radiation OncologyFeng-Ming Spring Kong, Kyle C Cuneo, Li Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|October 26, 2017
Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular CarcinomaEli Sapir, Yebin Tao, Matthew J Schipper, et al.
Physics in Medicine and Biology|February 13, 2023
Stereotactic body radiation therapy (SBRT) following Yttrium-90 (<sup>90</sup>Y) selective internal radiation therapy (SIRT): a feasibility planning study using<sup>90</sup>Y delivered doseStephen F Mee, Daniel F Polan, Yuni K Dewaraja, et al.
International Journal of Radiation Oncology, Biology, Physics|September 15, 2018
Magnetic Resonance Imaging Evaluation of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy: Long Term Imaging Follow-UpMishal Mendiratta-Lala, William Masch, Prasad R Shankar, et al.
Scientific Reports|January 26, 2019
PD-L1 Expression in Circulating Tumor Cells Increases during Radio(chemo)therapy and Indicates Poor Prognosis in Non-small Cell Lung CancerYang Wang, Tae Hyun Kim, Shamileh Fouladdel, et al.
Journal of Surgical Oncology|March 3, 2022
Factors associated with disease-free and abdominal recurrence-free survival in abdominopelvic and retroperitoneal sarcomasBrooke C Bredbeck, Lia D Delaney, Varun G Kathawate, et al.
Cancers|April 25, 2020
Expansion of Circulating Tumor Cells from Patients with Locally Advanced Pancreatic Cancer Enable Patient Derived Xenografts and Functional Studies for Personalized MedicineLianette Rivera-Báez, Ines Lohse, Eric Lin, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2023
Does Vascular Collapse Occur After Treatment of Hepatocellular Cancer With Stereotactic Body Radiation Therapy?Theodore S Lawrence, Madhava P Aryal, Joseph R Evans, et al.
Translational Oncology|May 12, 2019
Serum Levels of Hepatocyte Growth Factor and CD40 Ligand Predict Radiation-Induced Liver InjuryKyle C Cuneo, Theresa Devasia, Yilun Sun, et al.
International Journal of Radiation Oncology, Biology, Physics|September 9, 2019
Phase 2 Trial of Neoadjuvant FOLFIRINOX and Intensity Modulated Radiation Therapy Concurrent With Fixed-Dose Rate-Gemcitabine in Patients With Borderline Resectable Pancreatic CancerNguyen H Tran, Vaibhav Sahai, Kent A Griffith, et al.
Pageof 8